Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Unknown 3Terminated 2Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 40Lymphoid 32Other hematologic neoplasm 16CNS 12Genitourinary 8Other solid neoplasm 7Endocrine 5Gynecologic 4Plasma cell 3Sarcoma 2Myeloid 2NET 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Gastrointestinal Neoplasms 1Carcinoma, Neuroendocrine 1

Interventions

Oxaliplatin 197Bevacizumab 164Fluorouracil 153Gemcitabine 137Capecitabine 137Leucovorin 110pembrolizumab 102Cisplatin 98Drug Therapy 90Irinotecan 79Radiotherapy 73sintilimab 70130-nm albumin-bound paclitaxel 68durvalumab 67Paclitaxel 65Cetuximab 64Specimen Handling 62tislelizumab 60lenvatinib 60Magnetic Resonance Spectroscopy 57Folfox protocol 56Nivolumab 54Blood Specimen Collection 52Biopsy 48atezolizumab 47Surgical Procedures, Operative 40Taxes 39Albumin-Bound Paclitaxel 39Immune Checkpoint Inhibitors 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Etoposide × Gastrointestinal × Clear all
NCT04268121 2025-07-23

NEONEC

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Recruiting
78 enrolled
EndocrineGastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡